Status:
ACTIVE_NOT_RECRUITING
Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia
Lead Sponsor:
Shanghai General Hospital, China
Collaborating Sponsors:
First Affiliated Hospital of Chongqing Medical University
Conditions:
Severe Pneumonia
Eligibility:
All Genders
16+ years
Brief Summary
The goal of this longitudinal observational study is to investigate the pathogen spectrum composition of severe pneumonia (SP) in different disease stages and to study the changes of immune inflammato...
Detailed Description
This is a multi-center, longitudinal, observational study. Participants SP patients will be continuously recruited in ICU department in Shanghai General Hospital and respiratory-specific ICU (RICU) ...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Clinical diagnosed of severe pneumonia (case definition: adults according to "Diagnosis and Treatment of Adults with Community-acquired Pneumonia"-- An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America, 2019)
- Have at least one microbiological test result
Exclusion
- No data of clinical prognosis
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06538441
Start Date
August 1 2024
End Date
December 30 2025
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mei Kang
Shanghai, Shanghai Municipality, China, 200080